Woven Orthopedic Technologies, based in Manchester, is bringing its surgical screw sleeves, in development since 2013, to the U.S. market.
The FDA granted a so-called “de novo classification” to Woven’s OGmend Implant Enhancement System (pronounced similarly to “augment”) over the summer, allowing it to market the product for use during long-bone trauma surgeries.